World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
22252
World Ranking
18751
National Ranking
9342

Overview

Jeannette Y. Lee is affiliated with the University of Arkansas for Medical Sciences in the United States. Their primary field of study is Medicine, with a focus on oncology, epidemiology, surgery, pathology and forensic medicine, and public health, environmental and occupational health.

The scientist's research engages deeply with several main topics including:

  • Viral-associated cancers and disorders
  • Cervical Cancer and HPV Research
  • Colorectal and Anal Carcinomas
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Genital Health and Disease
  • Ethics in Clinical Research

Jeannette Y. Lee has contributed to numerous papers published in notable venues. Some of the recent publications include:

  • Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer, 2022, New England Journal of Medicine
  • Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial, 2020, The Lancet
  • Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial), 2020, Blood
  • High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus, 2021, Clinical Infectious Diseases
  • Treatment of Male Sexual Partners of Women With Bacterial Vaginosis: A Randomized, Double-Blind, Placebo-Controlled Trial, 2020, Clinical Infectious Diseases

The scientist frequently publishes in venues such as UNC Libraries, Contemporary Clinical Trials, Research Square, Clinical Infectious Diseases, and Trials.

Jeannette Y. Lee collaborates regularly with a group of coauthors, including Shelly Lensing, Joel M. Palefsky, Jessica Snowden, Elizabeth A. Stier, and Ronald T. Mitsuyasu. These collaborations indicate active engagement with peers in related fields of medical research.

Best Publications

  • POTENT SUPPRESSION OF HIV-1 REPLICATION IN HUMANS BY T-20, A PEPTIDE INHIBITOR OF GP41-MEDIATED VIRUS ENTRY

    J M Kilby;S Hopkins;T M Venetta;B DiMassimo

  • A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

    Peter G. Pappas;John H. Rex;Jeannette Lee;Richard J. Hamill

  • Prospective Multicenter Surveillance Study of Funguria in Hospitalized Patients

    Carol A. Kauffman;José A. Vazquez;Jack D. Sobel;Harry A. Gallis

  • A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects

    John H. Rex;John H. Rex;Peter G. Pappas;Adolf W. Karchmer;Jack Sobel

  • A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis

    D. A. Stevens;H. J. Schwartz;J. Y. Lee;B. L. Moskovitz

  • Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

    Luis Ostrosky-Zeichner;John H. Rex;Peter G. Pappas;Richard J. Hamill

  • The Impact of Culture Isolation of Aspergillus Species: A Hospital-Based Survey of Aspergillosis

    J. R. Perfect;G. M. Cox;J. Y. Lee;C. A. Kauffman

  • Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010

    Lawrence D. Kaplan;Jeannette Y. Lee;Richard F. Ambinder;Joseph A. Sparano

  • Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity

    Hitoshi Suzuki;Run Fan;Zhixin Zhang;Rhubell Brown

  • Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.

    Z. Moldoveanu;R.J. Wyatt;J.Y. Lee;M. Tomana

  • Supplementation with Folic Acid during Methotrexate Therapy for Rheumatoid Arthritis: A Double-Blind, Placebo-Controlled Trial

    Sarah L. Morgan;Joseph E. Baggott;William H. Vaughn;Janet S. Austin

  • Candiduria: A Randomized, Double-Blind Study of Treatment with Fluconazole and Placebo

    J. D. Sobel;C. A. Kauffman;D. McKinsey;M. Zervos

  • Trichosporon beigelii, an emerging pathogen resistant to amphotericin B.

    T J Walsh;G P Melcher;M G Rinaldi;J Lecciones

  • Chemotherapy for Human Immunodeficiency Virus–Associated Non-Hodgkin’s Lymphoma in Combination With Highly Active Antiretroviral Therapy

    Lee Ratner;Jeannette Lee;Shenghui Tang;David Redden

  • Mice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathy

    Douglas D. McCarthy;Julie Kujawa;Cheryl Wilson;Adrian Papandile

  • Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men

    Timothy Wilkin;Jeannette Y. Lee;Shelly Y. Lensing;Elizabeth A. Stier

  • Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

    Joseph A. Sparano;Jeannette Y. Lee;Lawrence D. Kaplan;Alexandra M. Levine

  • Re-Evaluating the Treatment of Nongonococcal Urethritis: Emphasizing Emerging Pathogens–A Randomized Clinical Trial

    J. R. Schwebke;A. Rompalo;S. Taylor;A. C. Seña

  • Prognostic indicators in patients with isolated local–regional recurrence of breast cancer

    John M. Bedwinek;Jeannette Lee;Barbara Fineberg;Maryann Ocwieza

  • Patients with igA nephropathy have increased serum galactose-deficient igA1 levels. Commentary

    A. Roos;C. Van Kooten;Z. Moldoveanu;R. J. Wyatt

Frequent Co-Authors

Joseph A. Sparano
Joseph A. Sparano Albert Einstein College of Medicine
Richard F. Ambinder
Richard F. Ambinder Johns Hopkins University
Joel M. Palefsky
Joel M. Palefsky University of California, San Francisco
John W. Kusek
John W. Kusek National Institutes of Health
Ronald T. Mitsuyasu
Ronald T. Mitsuyasu University of California, Los Angeles
Lee Ratner
Lee Ratner Washington University in St. Louis
Ethel Cesarman
Ethel Cesarman Cornell University
Jane R. Schwebke
Jane R. Schwebke University of Alabama at Birmingham
David T. Scadden
David T. Scadden Harvard University
Bruce J. Dezube
Bruce J. Dezube Beth Israel Deaconess Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine offers more than the traditional MD pathway. Numerous online programs allow aspiring healthcare professionals to begin or advance their careers from anywhere, with flexible schedules and options tailored to different interests.

For those interested in nursing, fast track lpn programs are a popular choice, offering a rapid route to becoming a Licensed Practical Nurse. Nurses aiming for advanced practice roles might consider the fastest pmhnp program to qualify as a Psychiatric Mental Health Nurse Practitioner, addressing the growing demand for mental health services.

Those drawn to leadership or administrative roles can pursue health administration degrees online, which provide the skills needed to manage healthcare facilities effectively. Additionally, obtaining an affordable mha online can open doors to higher-level management and policy positions without breaking the bank.

These online degree options offer flexibility, affordability, and specialized pathways for students passionate about healthcare, whether patient-facing or in behind-the-scenes roles.

Best Scientists Citing Jeannette Y. Lee

Trending Scientists

Recently Published Articles